Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Oriza, Boyu Join $150M Series A Round In Bio-Pharma Startup CStone
Venture Capital

Oriza, Boyu Join $150M Series A Round In Bio-Pharma Startup CStone

by chinamoneynetwork.com posted 2years ago 6859 views
Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have invested RMB975 million (US$150 million) in CStone Pharmaceuticals Co., Ltd, a bio-pharmaceutical company devoted to developing new treatments for various major diseases.